Identifying pathogenic proteins leads to potential new treatments for diseases such as diabetes.

Published Date: 02 Mar 2023

New research has identified hundreds of proteins that can lead to the development of metabolic diseases, such as type 2 diabetes mellitus, and therefore have treatment potential.

Read Full News

Latest News

Pfizer, Innovent GLP-1 Drugs Clear China Insurance Hurdle

GLP-1 drugs from Pfizer and Innovent Biologics have passed a preliminary review to be potentially included in China's basic medical ⁠insurance drug catalogue.

A Year After Keto: Fat Loss Persists, Metabolism Recovers

In women with obesity, a very low-calorie ketogenic diet followed by structured refeeding can help maintain meaningful weight loss at 1 year while allowing the body’s energy expenditure to recover.

Hybio's Generic Weight-loss Drug Set for FDA Review

The U.S. Food and Drug Administration has agreed to review ⁠Chinese generics drugmaker Hybio Pharmaceutical's two experimental generic tirzepatide GLP-1s that, if approved,...

Food Noise: a Real Phenomenon Deserving of Being Treated

Emerging evidence shows that many people experience food noise, that it can be measured and, at least to some extent, treated with a GLP-1 or other strategy.

FDA Staff Question Peptides Backed by Kennedy Ahead Of Advisory Panel Review

U.S. FDA staff reviewers said there is little evidence to allow compounding pharmacies to manufacture seven popular peptides, in stark contrast to Health Secretary Robert F....

US FDA Greenlights Viridian's Thyroid Eye Disease Drug

The U.S. Food and Drug Administration has approved Viridian Therapeutics' drug to treat patients with thyroid eye disease, the ⁠company said on Friday.

Todays Updates

Asian Women With Breast Cancer Outlive White Peers

Researchers seek to understand why Asian women fare better with the disease.

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Todays Updates

Asian Women With Breast Cancer Outlive White Peers

Researchers seek to understand why Asian women fare better with the disease.

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Latest News

GLP-1 drugs from Pfizer and Innovent Biologics have passed a preliminary review to be potentially included in China's basic medical ⁠insurance drug catalogue.

In women with obesity, a very low-calorie ketogenic diet followed by structured refeeding can help maintain meaningful weight loss at 1 year while allowing the body’s energy expenditure to recover.

The U.S. Food and Drug Administration has agreed to review ⁠Chinese generics drugmaker Hybio Pharmaceutical's two experimental generic tirzepatide GLP-1s that, if approved,...

Emerging evidence shows that many people experience food noise, that it can be measured and, at least to some extent, treated with a GLP-1 or other strategy.

U.S. FDA staff reviewers said there is little evidence to allow compounding pharmacies to manufacture seven popular peptides, in stark contrast to Health Secretary Robert F....

The U.S. Food and Drug Administration has approved Viridian Therapeutics' drug to treat patients with thyroid eye disease, the ⁠company said on Friday.

News All Time

Novo's Top US Exec Wants More Insurance Coverage for Weight-loss Drugs

Denmark's Novo Nordisk, the maker of weight-loss drug Wegovy, hopes insurance will cover more U.S. users of the medication and balance direct-to-consumer sales that have...

Two Studies Link GLP-1 Use to Lower Breast Cancer Risk

Two studies, including one involving more than 100,000 women, linked GLP-1 receptor agonists to reduced incidence of breast cancer.

Trump Pricing Policy Will Affect Obesity Drug Launch in Europe

Eli Lilly expects to launch its weight-loss pill in Europe and Britain in the second half of ⁠2026 or early 2027, with the drugmaker targeting the out-of-pocket telehealth market.

GLP-1 QOL Benefits Greatest for Those With Obesity Plus T2D

Patients with co-occurring obesity and T2D have more favorable QOL outcomes on GLP-1s than those with either condition alone or multiple comorbidities.

Mediterranean Diet May Reduce Postpartum Metabolic Risk

A Mediterranean-based nutritional intervention initiated at 8-12 gestational weeks is associated with a reduced risk for metabolic syndrome 6 years postpartum, a prospective follow-up study finds.

China Approval for Eli Lilly GLP-1 Pill to Come as Soon as 2026, Executive Says

Eli Lilly's orforglipron type-2 diabetes and obesity pill could launch in China as soon ⁠as later this year, an executive at the U.S. drugmaker told Reuters, as rival Novo...

Urogenital Infections Tied to SGLT2 Therapy Discontinuation

Patients with type 2 diabetes who start SGLT2 inhibitors and then develop a urinary or genital tract infection are more likely to discontinue treatment than matched patients without an infection.

Protein Source Key for Weight Loss After Menopause

Postmenopausal women are often encouraged to eat more protein, but a new study finds that protein source matters, with plant-based protein outperforming animal protein for weight loss.

What GLP-1s Are Teaching Us About Compulsive Behavior

As GLP-1 research moves deeper into the brain, scientists are asking whether these drugs can help explain why some urges become so hard to resist.

Fasting and Calorie Restriction Work via Different Pathways

In adults with obesity, both intermittent fasting and calorie restriction lead to significant weight loss but act through distinct behavioral pathways.

NHS Recommends First Drug to Delay Type 1 Diabetes

NICE has recommended teplizumab — the first medicine to delay type 1 diabetes onset — in what Diabetes UK calls ‘a new age of treatment.’

GLP-1s Tied to Reduced Opioid Use in Chronic Pancreatitis

Among patients with chronic pancreatitis, GLP‑1 treatment is associated with a lower likelihood of initiating long-term opioid therapy or developing opioid use disorder.

GLP-1 Era Demands a New Model of Obesity Care

Panelists at HLTH Europe 2026 say obesity care must shift to lifelong digital models and shed its stigma as a moral failing.

Erosive Hand OA Flags Fracture Risk in Postmenopausal Women

Erosive hand osteoarthritis is associated with an increased risk for incident osteoporotic fractures in postmenopausal women, a study finds.

Medicare to Cover New Osteoporosis Diagnostic Screening Test

Medicare coverage of a new osteoporosis screening tool may help to address the challenge of identifying and treating patients with osteoporosis by expanding access to screening.

10-Hour Eating Window Boosts Weight Loss in Obesity

10-hour time-restricted eating promotes greater weight loss and improved body composition in adults with obesity and without diabetes than standard dietary counseling alone.

Recommended News For You

Research indicates that combining AI models enhances the ability to predict breast cancer risk.

Cancer Diagnoses Slow to Recover From Effects of COVID Pandemic

The Growing Role of AI in Cancer Treatment

No Benefit for PD-1 Inhibitors in Certain Gastroesophageal Cancers, FDA Panel Says

From Pathology to Precision: The Story of Leukemia Therapy

Screening tests that are non-invasive show promise in detecting colorectal cancer.

O. A. J. Simpson passes away from cancer.

Recommended Articles For You

Gut microbiota in curing cancer 

Carboplatin Treatment: What You Need to Know About Side Effects and Efficacy  

Unraveling the Mystery of Non-Caseating Granulomas: A Comprehensive Guide 

The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Living near St. Louis-area Coldwater Creek during childhood linked with higher risk of cancer from radiation

2.

New policy review highlights the importance of health-related quality of life in advanced cancer

3.

In a randomized trial, the kinder, gentler regimen for classical Hodgkin wins out.

4.

Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement

5.

Kate Middleton Reaches Cancer Treatment Milestone

1.

MMA Embolization in Chronic Subdural Hematoma: Evidence, Outcomes, and Gaps

2.

Hemophilia Beyond Boundaries: Unconventional Therapies in Bleeding Disorder Care

3.

Decoding Hamartomas: Understanding Their Causes and Symptoms

4.

Exploring the Effects of Radiation Therapy on Cystitis: A Journey to Better Health

5.

Imaging in Peritoneal Neoplasms: Diagnostic Advances and Multimodal Treatment Strategies

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

2.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III

3.

Navigating the Complexities of Ph Negative ALL - Part XV

4.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

5.

Thromboprophylaxis In Medical Settings

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot